Innate Immunity System in Patients With Cardiovascular and Kidney Disease

Carmine Zoccali1, Francesca Mallamaci2

  • 1Renal Research Institute New York and Institute of Molecular Biology and genetics (BIOGEM), Ariano Irpino, Italy and Associazione Ipertensione, Nefrologia, Trapianto (IPNET), Reggio Calabria Italy (C.Z.).

Circulation Research
|April 13, 2023
PubMed

Insights

Chronic kidney disease (CKD) patients face high cardiovascular risk due to systemic inflammation. Targeting inflammation pathways shows promise for improving both kidney and heart health outcomes in CKD.

Area of Science:

  • Nephrology
  • Immunology
  • Cardiology

Background:

  • Chronic kidney disease (CKD) affects 844 million globally, posing a significant public health challenge.
  • Systemic inflammation is a key driver of cardiovascular complications in CKD patients.
  • Multiple factors contribute to severe inflammation in CKD, including cellular senescence and immune activation.

Purpose of the Study:

  • To explore the role of systemic inflammation in CKD progression and cardiovascular events.
  • To evaluate the potential of targeting innate immune responses for improved patient outcomes.
  • To review existing and emerging therapies aimed at mitigating inflammation in CKD.

Main Methods:

  • Analysis of cohort studies linking inflammation biomarkers to CKD progression and cardiovascular events.
  • Review of clinical trial data for anti-inflammatory agents in cardiovascular and kidney disease.
  • Examination of mechanisms driving inflammation in CKD, such as cellular senescence and immune activation.

Main Results:

  • Inflammation biomarkers are strongly associated with increased risk of kidney failure and cardiovascular events in CKD.
  • Inhibition of interleukin-1 beta (IL-1β) signaling reduced cardiovascular events in patients with coronary heart disease, including those with CKD.
  • Ongoing trials are investigating drugs like ziltivekimab (IL-6 antagonist) for CKD and cardiovascular benefits.

Conclusions:

  • Mitigating systemic inflammation is a promising therapeutic strategy for reducing cardiovascular and kidney disease risks in CKD patients.
  • Targeting innate immune pathways offers a potential avenue for novel treatments.
  • Further research and clinical trials are crucial to validate these anti-inflammatory approaches.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
48
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
37
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
32
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
30
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
11
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
45